Brief: Aroa Biosurgery Maintains FY25 Normalised EBITDA Profit Guidance

Aroa Biosurgery

24/07/2024 02:16

July 24 (Reuters) - Aroa Biosurgery Ltd  ARX.AX :
    * FY25 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED
    * FY25 REVENUE GUIDANCE MAINTAINED AT NZ$80-87 MILLION

Further company coverage:  ARX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))